Ipsen news | Ipsen Global

Stories

Discover all of the trending stories of Ipsen Group.

Explore more by category

Filter

Period

Filter by

recent search

Showing: 15 of 154 stories

H1 2025 Results
 • 0 mins read

 – 0 mins read

H1 2025 Results

Ipsen’s financial results for the first half of 2025 will be published on 31 July 2025 at 07:00 CET.


Céline and Suzanne: Navigating Alagille Syndrome
 • 2 mins read

 – 2 mins read

Céline and Suzanne: Navigating Alagille Syndrome

At just nine years old, Suzanne is a bright, creative young girl who loves dancing, drawing, exploring the woods, and watching birds. Despite living with Alagille syndrome (ALGS), a rare genetic condition, she embraces life with enthusiasm and curiosity.


Ipsen 2025 Annual General Meeting
 • 0 mins read

 – 0 mins read

Ipsen 2025 Annual General Meeting

A replay with complete presentation and Q&A session will be made available soon after the Annual General Meeting.


Q1 2025 sales update
 • 0 mins read

 – 0 mins read

Q1 2025 sales update

The financial results for the Full Year 2024 will be published on February 13, 2025 at 7H00 CET and a conference call will take place at 13H00 CET.


Living with Rare Liver Diseases: Unique challenges, Shared Experiences 
 • 2 mins read

 – 2 mins read

Living with Rare Liver Diseases: Unique challenges, Shared Experiences 

Cholestatic liver diseases are a rare but significant group of conditions that impact both children and adults. Three such conditions—Primary Biliary Cholangitis (PBC), Progressive Familial Intrahepatic Cholestasis (PFIC), and Alagille Syndrome (ALGS)—share commonalities yet are unique in their caus